Literature DB >> 15257061

Pharmacogenetics in immunosuppressive therapy: the best thing since TDM?

Teun van Gelder1, Dennis A Hesselink, Reinier M van Hest, Ron A A Mathôt, Ron van Schaik.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15257061     DOI： 10.1097/00007691-200408000-00001

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN： 0163-4356            Impact factor:   3.681


× No keyword cloud information.
  3 in total

1.  Pharmacodynamics of T-cell function for monitoring immunosuppression.

Authors:  M J Barten; A Tarnok; J Garbade; H B Bittner; S Dhein; F W Mohr; J F Gummert
Journal:  Cell Prolif       Date:  2007-02       Impact factor: 6.831

2.  Inosine Monophosphate Dehydrogenase Pharmacogenetics in Hematopoietic Cell Transplantation Patients.

Authors:  Jeannine S McCune; Barry Storer; Sushma Thomas; Jožefa McKiernan; Rohan Gupta; Brenda M Sandmaier
Journal:  Biol Blood Marrow Transplant       Date:  2018-04-12       Impact factor: 5.742

3.  Polymorphisms in type I and II inosine monophosphate dehydrogenase genes and association with clinical outcome in patients on mycophenolate mofetil.

Authors:  Olivier Gensburger; Ron H N Van Schaik; Nicolas Picard; Yannick Le Meur; Annick Rousseau; Jean-Baptiste Woillard; Teun Van Gelder; Pierre Marquet
Journal:  Pharmacogenet Genomics       Date:  2010-09       Impact factor: 2.089
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.